David Koch

Associate Professor

Medical University of South Carolina

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Koch is an Associate Professor at the Medical University of South Carolina, USA. His research focuses on hepatology, specifically investigating liver diseases, cardiometabolic risks, and treatment outcomes in patients with cirrhosis and fatty liver disease. Recent articles authored by Dr. Koch explore various aspects of liver health, including biomarkers for liver failure and the efficacy of treatments in chronic liver disease.

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Constantine Karvellas

Professor

University of Alberta

CANADA

View details

Michael Porayko

Professor of Medicine

Vanderbilt University Medical Center

UNITED STATES

View details

Andrew Schreiner

Associate Professor of Medicine

Medical University of South Carolina

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Koch

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites

Objective Measures of Cardiometabolic Risk and Advanced Fibrosis Risk Progression in Primary Care Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure

Real-World Primary Care Data Comparing ALT and FIB-4 in Predicting Future Severe Liver Disease Outcomes

Acute Liver Failure: Biomarkers Evaluated by the Acute Liver Failure Study Group.

FIB-4 as a Time-varying Covariate and Its Association With Severe Liver Disease in Primary Care: A Time-dependent Cox Regression Analysis.

Chronic liver disease is not associated with statin prescription in a primary care cohort.

FIB-4 and incident severe liver outcomes in patients with undiagnosed chronic liver disease: A Fine-Gray competing risk analysis

The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care

Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort.

Coagulopathy, Bleeding Events, and Outcome According to Rotational Thromboelastometry in Patients With Acute Liver Injury/Failure.

Prognostic Value of the C-Methacetin Breath Test in Adults with Acute Liver Failure and Non-acetaminophen Acute Liver Injury.

Collaborators (3)

Constantine Karvellas

Michael Porayko

Andrew Schreiner

Make your next move.